PubMed:14551220 / 194-367 JSONTXT

Annnotations TAB JSON ListView MergeView

    PubmedHPO

    {"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":155,"end":161},"obj":"HP_0002664"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    GlycoBiology-FMA

    {"project":"GlycoBiology-FMA","denotations":[{"id":"_T9","span":{"begin":15,"end":24},"obj":"FMAID:226028"},{"id":"_T10","span":{"begin":15,"end":24},"obj":"FMAID:226027"}],"namespaces":[{"prefix":"FMAID","uri":"http://purl.org/sig/ont/fma/fma"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    uniprot-human

    {"project":"uniprot-human","denotations":[{"id":"T36","span":{"begin":39,"end":70},"obj":"http://www.uniprot.org/uniprot/Q06430"},{"id":"T37","span":{"begin":39,"end":70},"obj":"http://www.uniprot.org/uniprot/Q8N0V5"},{"id":"T38","span":{"begin":39,"end":70},"obj":"http://www.uniprot.org/uniprot/Q8NFS9"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    uniprot-mouse

    {"project":"uniprot-mouse","denotations":[{"id":"T3","span":{"begin":39,"end":70},"obj":"http://www.uniprot.org/uniprot/P97402"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    GlycoBiology-NCBITAXON

    {"project":"GlycoBiology-NCBITAXON","denotations":[{"id":"T1","span":{"begin":155,"end":161},"obj":"http://purl.bioontology.org/ontology/NCBITAXON/6754"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T2","span":{"begin":0,"end":173},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":173},"obj":"Sentence"},{"id":"T2","span":{"begin":0,"end":173},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    GO-BP

    {"project":"GO-BP","denotations":[{"id":"T1","span":{"begin":39,"end":72},"obj":"http://purl.obolibrary.org/obo/GO_0030144"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    EDAM-topics

    {"project":"EDAM-topics","denotations":[{"id":"T3","span":{"begin":155,"end":161},"obj":"http://edamontology.org/topic_2640"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    EDAM-DFO

    {"project":"EDAM-DFO","denotations":[{"id":"T2","span":{"begin":91,"end":100},"obj":"http://edamontology.org/data_0883"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    GlyTouCan-IUPAC

    {"project":"GlyTouCan-IUPAC","denotations":[{"id":"GlycanIUPAC_T2","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G26693XF\""},{"id":"GlycanIUPAC_T14","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G01864SU\""},{"id":"GlycanIUPAC_T26","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G17605FD\""},{"id":"GlycanIUPAC_T38","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G41950LU\""},{"id":"GlycanIUPAC_T50","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G57195RJ\""},{"id":"GlycanIUPAC_T62","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G85391SA\""},{"id":"GlycanIUPAC_T74","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G89565QL\""},{"id":"GlycanIUPAC_T86","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G80869MR\""},{"id":"GlycanIUPAC_T98","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G55978NL\""},{"id":"GlycanIUPAC_T110","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G54644LT\""},{"id":"GlycanIUPAC_T122","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G25694UG\""},{"id":"GlycanIUPAC_T134","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G25126RB\""},{"id":"GlycanIUPAC_T146","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G51848AD\""},{"id":"GlycanIUPAC_T158","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G94667GM\""},{"id":"GlycanIUPAC_T170","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G30124BO\""},{"id":"GlycanIUPAC_T182","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G82777EZ\""},{"id":"GlycanIUPAC_T194","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G10151YZ\""},{"id":"GlycanIUPAC_T206","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G17585ZM\""},{"id":"GlycanIUPAC_T218","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G04411CJ\""},{"id":"GlycanIUPAC_T230","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G38254HJ\""},{"id":"GlycanIUPAC_T242","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G75188FS\""},{"id":"GlycanIUPAC_T254","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G70374VG\""},{"id":"GlycanIUPAC_T266","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G45176LJ\""},{"id":"GlycanIUPAC_T278","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G30874VW\""},{"id":"GlycanIUPAC_T290","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G69333MI\""},{"id":"GlycanIUPAC_T302","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G10676XO\""},{"id":"GlycanIUPAC_T314","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G14843DJ\""},{"id":"GlycanIUPAC_T326","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G47546FR\""},{"id":"GlycanIUPAC_T338","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G73695ZM\""},{"id":"GlycanIUPAC_T350","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G31923TJ\""},{"id":"GlycanIUPAC_T362","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G60519EP\""},{"id":"GlycanIUPAC_T374","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G07933IA\""},{"id":"GlycanIUPAC_T386","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G40745NH\""},{"id":"GlycanIUPAC_T398","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G54496YV\""},{"id":"GlycanIUPAC_T410","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G62953SQ\""},{"id":"GlycanIUPAC_T422","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G70070AY\""},{"id":"GlycanIUPAC_T434","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G78792WC\""},{"id":"GlycanIUPAC_T446","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G25238AV\""},{"id":"GlycanIUPAC_T458","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G40510DP\""},{"id":"GlycanIUPAC_T470","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G61120TK\""},{"id":"GlycanIUPAC_T482","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G41342KV\""},{"id":"GlycanIUPAC_T494","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G90703NA\""},{"id":"GlycanIUPAC_T506","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G01591HR\""},{"id":"GlycanIUPAC_T518","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G56520XN\""},{"id":"GlycanIUPAC_T530","span":{"begin":8,"end":14},"obj":"\"http://rdf.glycoinfo.org/glycan/G81830JX\""}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    NGLY1-deficiency

    {"project":"NGLY1-deficiency","denotations":[{"id":"PD-NGLY1-deficiency-B_T2","span":{"begin":8,"end":14},"obj":"chem:24139"}],"namespaces":[{"prefix":"hgnc","uri":"https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:"},{"prefix":"omim","uri":"https://www.omim.org/entry/"},{"prefix":"chem","uri":"https://pubchem.ncbi.nlm.nih.gov/compound/"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    HP-phenotype

    {"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":155,"end":161},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":155,"end":161},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}

    Lectin-Jamboree-Sentence

    {"project":"Lectin-Jamboree-Sentence","blocks":[{"id":"T2","span":{"begin":0,"end":173},"obj":"Sentence"}],"text":"beta1-6 GlcNAc branching, a product of N-acetylglucosaminyltransferase V (GnT-V), is a key structure that is associated with malignant transformations and cancer metastasis."}